Reuters reveals COVID and bust: China's private health system hurt by tough coronavirus controls | Reuters News Agency
Health

Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls

Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

Article Tags
Topics of Interest: Health
Type: Reuters Best
Sectors: Pharmaceuticals & Healthcare
Regions: Asia
Countries: China
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Significant National Story
FILE PHOTO: A medical staff in protective suit works at a nucleic acid testing laboratory of Nanjing First Hospital following a citywide mass testing for the coronavirus disease (COVID-19) in Nanjing, Jiangsu province, China July 24, 2021. cnsphoto via REUTERS/File Photo   ATTENTION EDITORS - THIS IMAGE WAS PROVIDED BY A THIRD PARTY. CHINA OUT.
Sign up for email updates
Subscribe
Sign up for email updates